BFA
NAVB

BlackRock Fund Advisors’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History

BlackRock Fund Advisors’s Portfolio NAVB Stock Details NAVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$266K Buy
20,892
+597
+3% +$9.47K ﹤0.01% 3353
2016
Q3 		$372K Sell
20,295
-41
-0.2% -$519 ﹤0.01% 3292
2016
Q2 		$216K Sell
20,336
-170,678
-89% -$3.35M ﹤0.01% 3421
2016
Q1 		$3.61M Sell
191,014
-10,392
-5% -$200K ﹤0.01% 2906
2015
Q4 		$5.36M Buy
201,406
+5,605
+3% +$195K ﹤0.01% 2803
2015
Q3 		$8.93M Sell
195,801
-1,307
-0.7% -$49.3K ﹤0.01% 2441
2015
Q2 		$6.35M Sell
197,108
-13,238
-6% -$385K ﹤0.01% 2786
2015
Q1 		$6.69M Buy
210,346
+4,138
+2% +$140K ﹤0.01% 2673
2014
Q4 		$7.79M Buy
206,208
+30,030
+17% +$826K ﹤0.01% 2615
2014
Q3 		$4.65M Sell
176,178
-8,248
-4% -$218K ﹤0.01% 2797
2014
Q2 		$5.46M Buy
184,426
+15,805
+9% +$511K ﹤0.01% 2785
2014
Q1 		$6.24M Buy
168,621
+6,788
+4% +$257K ﹤0.01% 2683
2013
Q4 		$6.7M Sell
161,833
-7,408
-4% -$290K ﹤0.01% 2629
2013
Q3 		$8.97M Buy
169,241
+19,372
+13% +$1.13M ﹤0.01% 2440
2013
Q2 		$8M Buy
+149,869
New +$7.48M ﹤0.01% 2396

Other funds holding NAVB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
SFS
Sowell Financial Services North Little Rock, Arkansas $2.7B AUM 22.62% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

BlackRock Fund Advisors's NAVB Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Navidea Biopharmaceuticals Inc. (NAVB) stake by 2.9% in Q4 2016, buying an estimated $9.47K and bringing the position to 20,892 shares worth $266K. The position accounts for ﹤0.01% of the portfolio, ranked #3353.

BlackRock Fund Advisors first reported a position in NAVB in Q2 2013 and has held it in 15 quarters since. The position peaked at $8.97M in Q3 2013. 55 funds tracked by Wall St. Rank hold NAVB as of Q4 2016.

  • BlackRock Fund Advisors held 20,892 shares of Navidea Biopharmaceuticals Inc. worth $266K as of Q4 2016.
  • BlackRock Fund Advisors bought 597 Navidea Biopharmaceuticals Inc. shares in Q4 2016, an estimated $9.47K.
  • Navidea Biopharmaceuticals Inc. made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3353 holding.
  • BlackRock Fund Advisors first reported a position in Navidea Biopharmaceuticals Inc. in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Fund Advisors's Navidea Biopharmaceuticals Inc. position peaked at $8.97M in Q3 2013.
  • 55 funds tracked by Wall St. Rank held Navidea Biopharmaceuticals Inc. as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.